Christine Soden

Christine Helen Soden currently works at Elementis Plc as Senior Independent Director since 2026.
Ms. Soden is Chief Financial Officer, Secretary & Director at Acacia Pharma Ltd. since 2015.
Ms. Soden is a Non-Executive Director at Arecor Ltd. Ms. Soden is Chief Financial Officer & Non-Executive Director at Vio Healthtech Ltd. since 2013.
Ms. Soden is a Non-Executive Director at Cell Therapy Catapult Ltd. since 2020.
Formerly, Ms. Soden was Independent Non-Executive Director at e-Therapeutics Plc from 2017 to 2020.
Ms. Soden was Independent Non-Executive Director at Arecor Therapeutics Plc from 2021 to 2025.
Ms. Soden was Finance Director at Chiroscience Group Plc in 1999.
Ms. Soden was Chief Financial Officer & Director at Optos Plc from 2010 to 2012.
Ms. Soden was CFO, Secretary & Non-Executive Director at Electrical Geodesics LLC.
Ms. Soden was Non-Executive Director at CT2 Ltd. Ms. Soden was Secretary & Executive Director at Acacia Pharma Group Ltd. in 2020.
Ms. Soden was Non-Executive Director at FutureNova Ltd. from 2017 to 2021.
Ms. Soden was Chief Operating Officer at BTG Ltd. from 2005 to 2009.
Ms. Soden was Chief Financial Officer at Celltech Chiroscience Plc.
Ms. Soden was Group Financial Controller at Medeva Plc.
Ms. Soden was Chief Financial Officer at Oxagen Ltd. Ms. Soden completed undergraduate education at the University of Durham.